Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Research Report 2026(Status and Outlook)
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on VPM1002 (Tuberculosis BCG Based Vaccine) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.VPM1002 is a recombinant live vaccine derived from classical BCG in which the ureC gene is replaced with Listeria listeriolysin O (hly) to enhance antigen presentation, aiming to induce broader innate and adaptive immune responses. It is intended for use across settings that include newborns, adolescents, and adults with high exposure risk. Development and clinical advancement have been led by Germany?s Vakzine Projekt Management (VPM) together with the Serum Institute of India (SII), and the candidate has entered multiple phase III trial frameworks, with potential indications spanning prevention of infection/persistent infection, prevention of disease, and prevention of recurrence.Market Opportunities & Drivers: How do global elimination goals and financing mechanisms amplify the clinical translation momentum of next-generation BCG?The UN High-Level Meeting and WHO investment initiatives have underscored the urgency of ?new tuberculosis vaccines,? while Gavi?s Board has included TB vaccines in its 2026?2030 investment strategy, establishing policy expectations for subsequent procurement and scale-up; in India, public-sector?led phase III programs provide real-world foundations for population-level validation. The challenge lies in endpoint readouts and regulatory alignment: in 2025, Indian regulators further required supplemental safety?efficacy materials for candidate vaccines, indicating that higher evidence thresholds and approval rigor will coexist.Industry/Supply Chain: From seed strain resources and quality control to phase II/III translation?who is bridging clinical development and access?Upstream activities involve recombinant BCG construction, seed-lot and process consistency validation; midstream focuses on aseptic manufacturing, cold chain, and release testing; downstream progress is driven by public funding working in tandem with large manufacturers to advance registration and access. Representative stakeholders include the Serum Institute of India as the lead developer/producer of VPM1002 and sponsor of multiple clinical trials; Germany?s Vakzine Projekt Management (renamed Serum Life Science Europe GmbH) providing European-side development and tech-transfer interfaces; and multi-country research networks (ICMR/South African cohorts, etc.) creating clinical validation settings across different populations. Trends: Which populations and use pathways are most ?front-running and implementable??The Prevention of Disease (POD) track targeting household close contacts combines epidemiological relevance with feasibility and has become a key entry point for phase III trials; Prevention of Infection (POI) in newborns/infants continues the timing of BCG vaccination, emphasizing advantages in safety and immunogenicity; prevention of recurrence among previously treated patients serves high-risk subgroups and complements chemotherapy regimens. Overall, the capacity for on-site vaccination and follow-up in high-burden settings will determine the speed of translation across these sub-segments.Regional Trends: How do India?s dual engines of clinical development and manufacturing, and Europe?s technology origin, interface with high-burden markets in Africa and Asia?India integrates public financing, patient enrollment, and large-scale manufacturing, undertaking core phase III tasks across both POD and POI paths; Europe anchors early proof-of-concept and technology out-transfer; Africa?exemplified by South Africa?s neonatal studies?accumulates safety and immunology evidence conducive to regional registration and vaccination pathway design; at the global level, multilateral mechanisms (such as Gavi and WHO technical advisory processes) provide policy and financing coordinates for potential inclusion in national immunization programs. Latest Developments 2025-03-25: Indian regulators requested supplemental safety?efficacy materials for TB vaccine candidates; official statements specify that VPM1002 is manufactured by the Serum Institute of India and that ICMR leads the evaluation? 2025-01-24: WHO PDVAC public materials indicate that phase III studies such as CTRI/2019/01/017026 have completed enrollment/follow-up milestones, with results pending, covering the POD pathway?2024-08: BMJ Open published the PreVenTB trial protocol, detailing a phase III design in India among household close contacts, comparing VPM1002/Immuvac with placebo, and outlining implementation specifics.
The global VPM1002 (Tuberculosis BCG Based Vaccine) market size was estimated at USD 400.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global VPM1002 (Tuberculosis BCG Based Vaccine) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global VPM1002 (Tuberculosis BCG Based Vaccine) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the VPM1002 (Tuberculosis BCG Based Vaccine) market.
Global VPM1002 (Tuberculosis BCG Based Vaccine) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Vakzine Projekt Management (VPM)
Serum Institute of India
Market Segmentation (by Type)
0.5 Ml Per Vial
1 Ml Per Vial
2 Ml Per Vial
Other
Market Segmentation (by Application)
0-5 Years Old
5-18 Years Old
18-45 Years Old
45-65 Years Old
?65 Years Old
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the VPM1002 (Tuberculosis BCG Based Vaccine) Market
Overview of the regional outlook of the VPM1002 (Tuberculosis BCG Based Vaccine) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the VPM1002 (Tuberculosis BCG Based Vaccine) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of VPM1002 (Tuberculosis BCG Based Vaccine), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global VPM1002 (Tuberculosis BCG Based Vaccine) market size was estimated at USD 400.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global VPM1002 (Tuberculosis BCG Based Vaccine) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global VPM1002 (Tuberculosis BCG Based Vaccine) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the VPM1002 (Tuberculosis BCG Based Vaccine) market.
Global VPM1002 (Tuberculosis BCG Based Vaccine) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Vakzine Projekt Management (VPM)
Serum Institute of India
Market Segmentation (by Type)
0.5 Ml Per Vial
1 Ml Per Vial
2 Ml Per Vial
Other
Market Segmentation (by Application)
0-5 Years Old
5-18 Years Old
18-45 Years Old
45-65 Years Old
?65 Years Old
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the VPM1002 (Tuberculosis BCG Based Vaccine) Market
Overview of the regional outlook of the VPM1002 (Tuberculosis BCG Based Vaccine) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the VPM1002 (Tuberculosis BCG Based Vaccine) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of VPM1002 (Tuberculosis BCG Based Vaccine), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of VPM1002 (Tuberculosis BCG Based Vaccine)
1.2 Key Market Segments
1.2.1 VPM1002 (Tuberculosis BCG Based Vaccine) Segment by Type
1.2.2 VPM1002 (Tuberculosis BCG Based Vaccine) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Product Life Cycle
3.3 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Manufacturers (2020-2025)
3.4 Global VPM1002 (Tuberculosis BCG Based Vaccine) Revenue Market Share by Manufacturers (2020-2025)
3.5 VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global VPM1002 (Tuberculosis BCG Based Vaccine) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 VPM1002 (Tuberculosis BCG Based Vaccine) Market Competitive Situation and Trends
3.8.1 VPM1002 (Tuberculosis BCG Based Vaccine) Market Concentration Rate
3.8.2 Global 5 and 10 Largest VPM1002 (Tuberculosis BCG Based Vaccine) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) INDUSTRY CHAIN ANALYSIS
4.1 VPM1002 (Tuberculosis BCG Based Vaccine) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to VPM1002 (Tuberculosis BCG Based Vaccine) Market
5.7 ESG Ratings of Leading Companies
6 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Type (2020-2025)
6.3 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Type (2020-2025)
6.4 Global VPM1002 (Tuberculosis BCG Based Vaccine) Price by Type (2020-2025)
7 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Sales by Application (2020-2025)
7.3 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD) by Application (2020-2025)
7.4 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Growth Rate by Application (2020-2025)
8 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET SALES BY REGION
8.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region
8.1.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region
8.1.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Region
8.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region
8.2.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region
8.2.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region
8.3 North America
8.3.1 North America VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Country
8.3.2 North America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Country
8.4.2 Europe VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region
8.5.2 Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Country
8.6.2 South America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region
8.7.2 Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET PRODUCTION BY REGION
9.1 Global Production of VPM1002 (Tuberculosis BCG Based Vaccine) by Region(2020-2025)
9.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Revenue Market Share by Region (2020-2025)
9.3 Global VPM1002 (Tuberculosis BCG Based Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America VPM1002 (Tuberculosis BCG Based Vaccine) Production
9.4.1 North America VPM1002 (Tuberculosis BCG Based Vaccine) Production Growth Rate (2020-2025)
9.4.2 North America VPM1002 (Tuberculosis BCG Based Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe VPM1002 (Tuberculosis BCG Based Vaccine) Production
9.5.1 Europe VPM1002 (Tuberculosis BCG Based Vaccine) Production Growth Rate (2020-2025)
9.5.2 Europe VPM1002 (Tuberculosis BCG Based Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan VPM1002 (Tuberculosis BCG Based Vaccine) Production (2020-2025)
9.6.1 Japan VPM1002 (Tuberculosis BCG Based Vaccine) Production Growth Rate (2020-2025)
9.6.2 Japan VPM1002 (Tuberculosis BCG Based Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China VPM1002 (Tuberculosis BCG Based Vaccine) Production (2020-2025)
9.7.1 China VPM1002 (Tuberculosis BCG Based Vaccine) Production Growth Rate (2020-2025)
9.7.2 China VPM1002 (Tuberculosis BCG Based Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Vakzine Projekt Management (VPM)
10.1.1 Vakzine Projekt Management (VPM) Basic Information
10.1.2 Vakzine Projekt Management (VPM) VPM1002 (Tuberculosis BCG Based Vaccine) Product Overview
10.1.3 Vakzine Projekt Management (VPM) VPM1002 (Tuberculosis BCG Based Vaccine) Product Market Performance
10.1.4 Vakzine Projekt Management (VPM) Business Overview
10.1.5 Vakzine Projekt Management (VPM) SWOT Analysis
10.1.6 Vakzine Projekt Management (VPM) Recent Developments
10.2 Serum Institute of India
10.2.1 Serum Institute of India Basic Information
10.2.2 Serum Institute of India VPM1002 (Tuberculosis BCG Based Vaccine) Product Overview
10.2.3 Serum Institute of India VPM1002 (Tuberculosis BCG Based Vaccine) Product Market Performance
10.2.4 Serum Institute of India Business Overview
10.2.5 Serum Institute of India SWOT Analysis
10.2.6 Serum Institute of India Recent Developments
11 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET FORECAST BY REGION
11.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast
11.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Country
11.2.3 Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Region
11.2.4 South America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of VPM1002 (Tuberculosis BCG Based Vaccine) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of VPM1002 (Tuberculosis BCG Based Vaccine) by Type (2026-2035)
12.1.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of VPM1002 (Tuberculosis BCG Based Vaccine) by Type (2026-2035)
12.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Forecast by Application (2026-2035)
12.2.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales (K MT) Forecast by Application
12.2.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of VPM1002 (Tuberculosis BCG Based Vaccine)
1.2 Key Market Segments
1.2.1 VPM1002 (Tuberculosis BCG Based Vaccine) Segment by Type
1.2.2 VPM1002 (Tuberculosis BCG Based Vaccine) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Product Life Cycle
3.3 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Manufacturers (2020-2025)
3.4 Global VPM1002 (Tuberculosis BCG Based Vaccine) Revenue Market Share by Manufacturers (2020-2025)
3.5 VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global VPM1002 (Tuberculosis BCG Based Vaccine) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 VPM1002 (Tuberculosis BCG Based Vaccine) Market Competitive Situation and Trends
3.8.1 VPM1002 (Tuberculosis BCG Based Vaccine) Market Concentration Rate
3.8.2 Global 5 and 10 Largest VPM1002 (Tuberculosis BCG Based Vaccine) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) INDUSTRY CHAIN ANALYSIS
4.1 VPM1002 (Tuberculosis BCG Based Vaccine) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to VPM1002 (Tuberculosis BCG Based Vaccine) Market
5.7 ESG Ratings of Leading Companies
6 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Type (2020-2025)
6.3 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Type (2020-2025)
6.4 Global VPM1002 (Tuberculosis BCG Based Vaccine) Price by Type (2020-2025)
7 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Sales by Application (2020-2025)
7.3 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD) by Application (2020-2025)
7.4 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Growth Rate by Application (2020-2025)
8 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET SALES BY REGION
8.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region
8.1.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region
8.1.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Region
8.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region
8.2.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region
8.2.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region
8.3 North America
8.3.1 North America VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Country
8.3.2 North America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Country
8.4.2 Europe VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region
8.5.2 Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Country
8.6.2 South America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region
8.7.2 Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET PRODUCTION BY REGION
9.1 Global Production of VPM1002 (Tuberculosis BCG Based Vaccine) by Region(2020-2025)
9.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Revenue Market Share by Region (2020-2025)
9.3 Global VPM1002 (Tuberculosis BCG Based Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America VPM1002 (Tuberculosis BCG Based Vaccine) Production
9.4.1 North America VPM1002 (Tuberculosis BCG Based Vaccine) Production Growth Rate (2020-2025)
9.4.2 North America VPM1002 (Tuberculosis BCG Based Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe VPM1002 (Tuberculosis BCG Based Vaccine) Production
9.5.1 Europe VPM1002 (Tuberculosis BCG Based Vaccine) Production Growth Rate (2020-2025)
9.5.2 Europe VPM1002 (Tuberculosis BCG Based Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan VPM1002 (Tuberculosis BCG Based Vaccine) Production (2020-2025)
9.6.1 Japan VPM1002 (Tuberculosis BCG Based Vaccine) Production Growth Rate (2020-2025)
9.6.2 Japan VPM1002 (Tuberculosis BCG Based Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China VPM1002 (Tuberculosis BCG Based Vaccine) Production (2020-2025)
9.7.1 China VPM1002 (Tuberculosis BCG Based Vaccine) Production Growth Rate (2020-2025)
9.7.2 China VPM1002 (Tuberculosis BCG Based Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Vakzine Projekt Management (VPM)
10.1.1 Vakzine Projekt Management (VPM) Basic Information
10.1.2 Vakzine Projekt Management (VPM) VPM1002 (Tuberculosis BCG Based Vaccine) Product Overview
10.1.3 Vakzine Projekt Management (VPM) VPM1002 (Tuberculosis BCG Based Vaccine) Product Market Performance
10.1.4 Vakzine Projekt Management (VPM) Business Overview
10.1.5 Vakzine Projekt Management (VPM) SWOT Analysis
10.1.6 Vakzine Projekt Management (VPM) Recent Developments
10.2 Serum Institute of India
10.2.1 Serum Institute of India Basic Information
10.2.2 Serum Institute of India VPM1002 (Tuberculosis BCG Based Vaccine) Product Overview
10.2.3 Serum Institute of India VPM1002 (Tuberculosis BCG Based Vaccine) Product Market Performance
10.2.4 Serum Institute of India Business Overview
10.2.5 Serum Institute of India SWOT Analysis
10.2.6 Serum Institute of India Recent Developments
11 VPM1002 (TUBERCULOSIS BCG BASED VACCINE) MARKET FORECAST BY REGION
11.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast
11.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Country
11.2.3 Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Region
11.2.4 South America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of VPM1002 (Tuberculosis BCG Based Vaccine) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of VPM1002 (Tuberculosis BCG Based Vaccine) by Type (2026-2035)
12.1.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of VPM1002 (Tuberculosis BCG Based Vaccine) by Type (2026-2035)
12.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Forecast by Application (2026-2035)
12.2.1 Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales (K MT) Forecast by Application
12.2.2 Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Type (M USD)
Table 4. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Application
Table 5. VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Comparison by Region (M USD)
Table 6. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global VPM1002 (Tuberculosis BCG Based Vaccine) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global VPM1002 (Tuberculosis BCG Based Vaccine) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in VPM1002 (Tuberculosis BCG Based Vaccine) as of 2025)
Table 11. Global Market VPM1002 (Tuberculosis BCG Based Vaccine) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global VPM1002 (Tuberculosis BCG Based Vaccine) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. VPM1002 (Tuberculosis BCG Based Vaccine) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Type (K MT)
Table 27. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Type (M USD)
Table 28. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales (K MT) by Type (2020-2025)
Table 29. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Type (2020-2025)
Table 30. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD) by Type (2020-2025)
Table 31. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Type (2020-2025)
Table 32. Global VPM1002 (Tuberculosis BCG Based Vaccine) Price (USD/KG) by Type (2020-2025)
Table 33. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales (K MT) by Application
Table 34. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Application
Table 35. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Application (2020-2025) & (K MT)
Table 36. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Application (2020-2025)
Table 37. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Application (2020-2025) & (M USD)
Table 38. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Application (2020-2025)
Table 39. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Growth Rate by Application (2020-2025)
Table 40. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region (2020-2025) & (K MT)
Table 41. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Region (2020-2025)
Table 42. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region (2020-2025) & (M USD)
Table 43. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region (2020-2025)
Table 44. North America VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Country (2020-2025) & (K MT)
Table 45. North America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Country (2020-2025) & (K MT)
Table 47. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region (2020-2025) & (M USD)
Table 50. South America VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Country (2020-2025) & (K MT)
Table 51. South America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region (2020-2025) & (M USD)
Table 54. Global VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT) by Region(2020-2025)
Table 55. Global VPM1002 (Tuberculosis BCG Based Vaccine) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global VPM1002 (Tuberculosis BCG Based Vaccine) Revenue Market Share by Region (2020-2025)
Table 57. Global VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Vakzine Projekt Management (VPM) Basic Information
Table 63. Vakzine Projekt Management (VPM) VPM1002 (Tuberculosis BCG Based Vaccine) Product Overview
Table 64. Vakzine Projekt Management (VPM) VPM1002 (Tuberculosis BCG Based Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Vakzine Projekt Management (VPM) Business Overview
Table 66. Vakzine Projekt Management (VPM) SWOT Analysis
Table 67. Vakzine Projekt Management (VPM) Recent Developments
Table 68. Serum Institute of India Basic Information
Table 69. Serum Institute of India VPM1002 (Tuberculosis BCG Based Vaccine) Product Overview
Table 70. Serum Institute of India VPM1002 (Tuberculosis BCG Based Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Serum Institute of India Business Overview
Table 72. Serum Institute of India SWOT Analysis
Table 73. Serum Institute of India Recent Developments
Table 74. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Region (2026-2035) & (K MT)
Table 75. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Region (2026-2035) & (M USD)
Table 76. North America VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Country (2026-2035) & (K MT)
Table 77. North America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 78. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Country (2026-2035) & (K MT)
Table 79. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 80. Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Region (2026-2035) & (K MT)
Table 81. Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Region (2026-2035) & (M USD)
Table 82. South America VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Country (2026-2035) & (K MT)
Table 83. South America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 84. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Country (2026-2035) & (Units)
Table 85. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 86. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Type (2026-2035) & (K MT)
Table 87. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Type (2026-2035) & (M USD)
Table 88. Global VPM1002 (Tuberculosis BCG Based Vaccine) Price Forecast by Type (2026-2035) & (USD/KG)
Table 89. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales (K MT) Forecast by Application (2026-2035)
Table 90. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Type (M USD)
Table 4. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Application
Table 5. VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Comparison by Region (M USD)
Table 6. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global VPM1002 (Tuberculosis BCG Based Vaccine) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global VPM1002 (Tuberculosis BCG Based Vaccine) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in VPM1002 (Tuberculosis BCG Based Vaccine) as of 2025)
Table 11. Global Market VPM1002 (Tuberculosis BCG Based Vaccine) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global VPM1002 (Tuberculosis BCG Based Vaccine) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. VPM1002 (Tuberculosis BCG Based Vaccine) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Type (K MT)
Table 27. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Type (M USD)
Table 28. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales (K MT) by Type (2020-2025)
Table 29. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Type (2020-2025)
Table 30. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD) by Type (2020-2025)
Table 31. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Type (2020-2025)
Table 32. Global VPM1002 (Tuberculosis BCG Based Vaccine) Price (USD/KG) by Type (2020-2025)
Table 33. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales (K MT) by Application
Table 34. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Application
Table 35. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Application (2020-2025) & (K MT)
Table 36. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Application (2020-2025)
Table 37. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Application (2020-2025) & (M USD)
Table 38. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Application (2020-2025)
Table 39. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Growth Rate by Application (2020-2025)
Table 40. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region (2020-2025) & (K MT)
Table 41. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Region (2020-2025)
Table 42. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region (2020-2025) & (M USD)
Table 43. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region (2020-2025)
Table 44. North America VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Country (2020-2025) & (K MT)
Table 45. North America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Country (2020-2025) & (K MT)
Table 47. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region (2020-2025) & (M USD)
Table 50. South America VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Country (2020-2025) & (K MT)
Table 51. South America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region (2020-2025) & (M USD)
Table 54. Global VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT) by Region(2020-2025)
Table 55. Global VPM1002 (Tuberculosis BCG Based Vaccine) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global VPM1002 (Tuberculosis BCG Based Vaccine) Revenue Market Share by Region (2020-2025)
Table 57. Global VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Vakzine Projekt Management (VPM) Basic Information
Table 63. Vakzine Projekt Management (VPM) VPM1002 (Tuberculosis BCG Based Vaccine) Product Overview
Table 64. Vakzine Projekt Management (VPM) VPM1002 (Tuberculosis BCG Based Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Vakzine Projekt Management (VPM) Business Overview
Table 66. Vakzine Projekt Management (VPM) SWOT Analysis
Table 67. Vakzine Projekt Management (VPM) Recent Developments
Table 68. Serum Institute of India Basic Information
Table 69. Serum Institute of India VPM1002 (Tuberculosis BCG Based Vaccine) Product Overview
Table 70. Serum Institute of India VPM1002 (Tuberculosis BCG Based Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Serum Institute of India Business Overview
Table 72. Serum Institute of India SWOT Analysis
Table 73. Serum Institute of India Recent Developments
Table 74. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Region (2026-2035) & (K MT)
Table 75. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Region (2026-2035) & (M USD)
Table 76. North America VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Country (2026-2035) & (K MT)
Table 77. North America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 78. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Country (2026-2035) & (K MT)
Table 79. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 80. Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Region (2026-2035) & (K MT)
Table 81. Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Region (2026-2035) & (M USD)
Table 82. South America VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Country (2026-2035) & (K MT)
Table 83. South America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 84. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Country (2026-2035) & (Units)
Table 85. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 86. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Type (2026-2035) & (K MT)
Table 87. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Type (2026-2035) & (M USD)
Table 88. Global VPM1002 (Tuberculosis BCG Based Vaccine) Price Forecast by Type (2026-2035) & (USD/KG)
Table 89. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales (K MT) Forecast by Application (2026-2035)
Table 90. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of VPM1002 (Tuberculosis BCG Based Vaccine)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD), 2025-2035
Figure 5. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD) (2020-2035)
Figure 6. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global VPM1002 (Tuberculosis BCG Based Vaccine) Product Life Cycle
Figure 13. VPM1002 (Tuberculosis BCG Based Vaccine) Sales Share by Manufacturers in 2025
Figure 14. Global VPM1002 (Tuberculosis BCG Based Vaccine) Revenue Share by Manufacturers in 2025
Figure 15. VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market VPM1002 (Tuberculosis BCG Based Vaccine) Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by VPM1002 (Tuberculosis BCG Based Vaccine) Revenue in 2025
Figure 18. Industry Chain Map of VPM1002 (Tuberculosis BCG Based Vaccine)
Figure 19. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market PEST Analysis
Figure 20. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Type
Figure 27. Sales Market Share of VPM1002 (Tuberculosis BCG Based Vaccine) by Type (2020-2025)
Figure 28. Sales Market Share of VPM1002 (Tuberculosis BCG Based Vaccine) by Type in 2025
Figure 29. Market Share of VPM1002 (Tuberculosis BCG Based Vaccine) by Type (2020-2025)
Figure 30. Market Share of VPM1002 (Tuberculosis BCG Based Vaccine) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Application
Figure 33. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Application (2020-2025)
Figure 34. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Application in 2025
Figure 35. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Application (2020-2025)
Figure 36. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Application in 2025
Figure 37. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Growth Rate by Application (2020-2025)
Figure 38. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Region (2020-2025)
Figure 39. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region (2020-2025)
Figure 40. North America VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Country in 2024
Figure 43. North America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country in 2024
Figure 45. U.S. VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada VPM1002 (Tuberculosis BCG Based Vaccine) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico VPM1002 (Tuberculosis BCG Based Vaccine) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Country in 2024
Figure 53. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country in 2024
Figure 55. Germany VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Region in 2024
Figure 67. Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region in 2024
Figure 68. China VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (K MT)
Figure 79. South America VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Country in 2024
Figure 80. South America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (M USD)
Figure 81. South America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country in 2024
Figure 82. Brazil VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region in 2024
Figure 92. Saudi Arabia VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global VPM1002 (Tuberculosis BCG Based Vaccine) Production Market Share by Region (2020-2025)
Figure 103. North America VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT) Growth Rate (2020-2025)
Figure 106. China VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share Forecast by Type (2026-2035)
Figure 111. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Application (2026-2035)
Figure 112. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of VPM1002 (Tuberculosis BCG Based Vaccine)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD), 2025-2035
Figure 5. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD) (2020-2035)
Figure 6. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global VPM1002 (Tuberculosis BCG Based Vaccine) Product Life Cycle
Figure 13. VPM1002 (Tuberculosis BCG Based Vaccine) Sales Share by Manufacturers in 2025
Figure 14. Global VPM1002 (Tuberculosis BCG Based Vaccine) Revenue Share by Manufacturers in 2025
Figure 15. VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market VPM1002 (Tuberculosis BCG Based Vaccine) Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by VPM1002 (Tuberculosis BCG Based Vaccine) Revenue in 2025
Figure 18. Industry Chain Map of VPM1002 (Tuberculosis BCG Based Vaccine)
Figure 19. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market PEST Analysis
Figure 20. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Type
Figure 27. Sales Market Share of VPM1002 (Tuberculosis BCG Based Vaccine) by Type (2020-2025)
Figure 28. Sales Market Share of VPM1002 (Tuberculosis BCG Based Vaccine) by Type in 2025
Figure 29. Market Share of VPM1002 (Tuberculosis BCG Based Vaccine) by Type (2020-2025)
Figure 30. Market Share of VPM1002 (Tuberculosis BCG Based Vaccine) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Application
Figure 33. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Application (2020-2025)
Figure 34. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Application in 2025
Figure 35. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Application (2020-2025)
Figure 36. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share by Application in 2025
Figure 37. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Growth Rate by Application (2020-2025)
Figure 38. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Region (2020-2025)
Figure 39. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region (2020-2025)
Figure 40. North America VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Country in 2024
Figure 43. North America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country in 2024
Figure 45. U.S. VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada VPM1002 (Tuberculosis BCG Based Vaccine) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico VPM1002 (Tuberculosis BCG Based Vaccine) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico VPM1002 (Tuberculosis BCG Based Vaccine) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Country in 2024
Figure 53. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country in 2024
Figure 55. Germany VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Region in 2024
Figure 67. Asia Pacific VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region in 2024
Figure 68. China VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (K MT)
Figure 79. South America VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Country in 2024
Figure 80. South America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (M USD)
Figure 81. South America VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Country in 2024
Figure 82. Brazil VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa VPM1002 (Tuberculosis BCG Based Vaccine) Market Size by Region in 2024
Figure 92. Saudi Arabia VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa VPM1002 (Tuberculosis BCG Based Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa VPM1002 (Tuberculosis BCG Based Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global VPM1002 (Tuberculosis BCG Based Vaccine) Production Market Share by Region (2020-2025)
Figure 103. North America VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT) Growth Rate (2020-2025)
Figure 106. China VPM1002 (Tuberculosis BCG Based Vaccine) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share Forecast by Type (2026-2035)
Figure 111. Global VPM1002 (Tuberculosis BCG Based Vaccine) Sales Forecast by Application (2026-2035)
Figure 112. Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Share Forecast by Application (2026-2035)
